Nasdaq Biotechnology Index ends the first half of the year climbing over 14% Weekly chart
The NASDAQ Biotech Index ($ NBI) is currently evolving in a well-marked down channel formed by DR1 and suppoty DS1 resistance. In a few days, sellers should test the very strong resistance of $ 3200. This resistance was broken sharply during the fall of the end of 2018, which made it very fragile. The most likely scenario (72%) would be that the resistance of $...
The NBI weekly chart corresponds to the article "NASDAQ Biotechnology Index Analysis." The Live Trade Room.
NASDAQ BIOTECHNOLOGY INDEX: NBI A good low risk Buy Point Coming Up Range trading between the parallels continues as it has done since last year's election low. It' looks like it should fall back to 3267 where it becomes a buy again with stops just under 3250. It should make a strong rally from here back up to 3575 for about 300 points gain, with the first...
Sangamo Daily Chart. Weekly Looking good NASDAQ:SGMO
Biotech bubble has burst. Every rallies are to be sold, and despite the euphoria/new highs in S&P and Nasdaq have barely registered a decent retracement in the biotech sector.. Here's a larger picture of how far biotechs have went since 2008: The uptrend in S&P is limited, and it will only be a matter of time before it collapses off this rising wedge....